Weight-loss drugs plus exercise for obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether two weight-loss medications, semaglutide and tirzepatide, combined with an exercise program can help people with obesity lose weight. It may help you if you are looking for a structured medical approach to weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 60 years old
- Your body mass index (BMI) is between 30 and 40
- You are willing to participate voluntarily
- You are not a smoker
- You are not pregnant
- You have no recent lower leg injury or surgery (within the last 6 months)
- You do not have diabetes or related complications like kidney, eye, or nerve problems
- You do not have heart conditions, high blood pressure, or breathing problems that are not controlled
- You have not had weight-loss surgery or an endoscopy in the last year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.